Antipsychotic prescribing in care homes before and after launch of a national dementia strategy

An observational study (2015) in English institutions over a 4-year period | BMJ Open PDF Strengths and limitations of this study To our knowledge, this is the first UK study to examine long-term impact of a national policy initiative on antipsychotic prescribing in carehomes. The samples studied are many times those of other UK antipsychoticContinue reading “Antipsychotic prescribing in care homes before and after launch of a national dementia strategy”

Increased prescribing has little effect on depression levels in care homes

According to a study by the Universities of Cambridge and East Anglia dating from 1991-2011, antidepressant use in care homes has risen from 7.4 per cent to 29.2 per cent, although the prevalence of depression in care homes remains unchanged at around one in ten residents. The findings have prompted lead study author Prof AntonyContinue reading “Increased prescribing has little effect on depression levels in care homes”

Antipsychotics and other perils of prescribing – A physician’s tale

Clive Bowman, Residential Forum member, has kindly prepared this blog based on a talk given to a “DoL’s” conference in March 2018 Many years ago, and on the face of it an unremarkable request made by an experienced and wise GP to attend an aged lady in a Residential Home because of anxiety, you justContinue reading “Antipsychotics and other perils of prescribing
– A physician’s tale”